| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.86 | 0.002 | 0.869 | Androgen antagonist | 0.869 0.002 DBMET03442 | DBMET03442 | |
| 0.813 | 0.002 | 0.813 | Anesthetic general | 0.767 0.003 DBMET03442 | ||
| 0.801 | 0.015 | 0.837 | Antiinflammatory | 0.837 0.011 DBMET03442 | DBMET03442 | |
| 0.782 | 0.002 | 0.782 | GABA receptor agonist | 0.511 0.004 DBMET03442 | ||
| 0.778 | 0.014 | 0.778 | Transcription factor NF kappa B inhibitor | 0.762 0.015 DBMET03442 | ||
| 0.744 | 0.002 | 0.744 | GABA A receptor agonist | 0.45 0.004 DBMET03442 | ||
| 0.741 | 0.003 | 0.741 | GABA receptor antagonist | 0.446 0.004 DBMET03442 | ||
| 0.72 | 0.003 | 0.72 | GABA A receptor antagonist | 0.417 0.004 DBMET03442 | ||
| 0.715 | 0.001 | 0.715 | Glucose-6-phosphate dehydrogenase inhibitor | 0.272 0.001 DBMET03442 | ||
| 0.694 | 0.002 | 0.694 | Neurotrophic factor enhancer | 0.607 0.003 DBMET03442 | ||
| 0.719 | 0.028 | 0.719 | Apoptosis agonist | 0.713 0.028 DBMET03442 | ||
| 0.678 | 0.001 | 0.678 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.536 0.001 DBMET03442 | ||
| 0.677 | 0.016 | 0.677 | Analgesic | 0.334 0.118 DBMET03442 | ||
| 0.66 | 0.011 | 0.683 | Cholesterol antagonist | 0.683 0.009 DBMET03442 | DBMET03442 | |
| 0.592 | 0.002 | 0.592 | Lipocortins synthesis antagonist | 0.587 0.002 DBMET03442 | ||
| 0.604 | 0.035 | 0.77 | Caspase 9 stimulant | 0.77 0.015 DBMET03442 | DBMET03442 | |
| 0.565 | 0.002 | 0.565 | Progesterone antagonist | 0.386 0.003 DBMET03442 | ||
| 0.551 | 0.003 | 0.553 | Sodium/bile acid cotransporter inhibitor | 0.553 0.002 DBMET03442 | DBMET03442 | |
| 0.545 | 0.005 | 0.545 | Diuretic | 0.376 0.014 DBMET03442 | ||
| 0.542 | 0.004 | 0.723 | Interleukin 6 antagonist | 0.723 0.002 DBMET03442 | DBMET03442 | |
| 0.566 | 0.034 | 0.566 | Cyclophilin D inhibitor | 0.474 0.058 DBMET03442 | ||
| 0.527 | 0.002 | 0.527 | Estradiol 17 beta-dehydrogenase inhibitor | 0.443 0.002 DBMET03442 | ||
| 0.525 | 0.004 | 0.525 | Growth factor agonist | 0.311 0.013 DBMET03442 | ||
| 0.523 | 0.014 | 0.529 | Nitric oxide antagonist | 0.529 0.014 DBMET03442 | DBMET03442 | |
| 0.538 | 0.03 | 0.538 | Antiobesity | 0.318 0.104 DBMET03442 | ||
| 0.513 | 0.008 | 0.513 | P-glycoprotein inhibitor | 0.474 0.01 DBMET03442 | ||
| 0.495 | 0.006 | 0.516 | Interferon gamma antagonist | 0.516 0.005 DBMET03442 | DBMET03442 | |
| 0.491 | 0.015 | 0.491 | Hypoxia-inducible factor 1 alpha inhibitor | 0.454 0.02 DBMET03442 | ||
| 0.495 | 0.034 | 0.539 | Immunosuppressant | 0.539 0.023 DBMET03442 | DBMET03442 | |
| 0.424 | 0.002 | 0.424 | Aldosterone antagonist | 0.244 0.003 DBMET03442 | ||
| 0.421 | 0.004 | 0.421 | Aromatase inhibitor | 0.337 0.004 DBMET03442 | ||
| 0.412 | 0.004 | 0.461 | Cholesterol synthesis inhibitor | 0.461 0.003 DBMET03442 | DBMET03442 | |
| 0.384 | 0.002 | 0.384 | 5-Alpha-reductase inhibitor | 0.302 0.003 DBMET03442 | ||
| 0.392 | 0.014 | 0.427 | Hepatoprotectant | 0.427 0.011 DBMET03442 | DBMET03442 | |
| 0.405 | 0.037 | 0.405 | Apoptosis antagonist | 0.388 0.042 DBMET03442 | ||
| 0.376 | 0.009 | 0.376 | NOS3 expression enhancer | 0.326 0.014 DBMET03442 | ||
| 0.35 | 0.002 | 0.35 | RNA-directed RNA polymerase stimulant | 0.329 0.002 DBMET03442 | ||
| 0.349 | 0.003 | 0.418 | Androgen agonist | 0.418 0.002 DBMET03442 | DBMET03442 | |
| 0.372 | 0.03 | 0.372 | Hypolipemic | 0.357 0.034 DBMET03442 | ||
| 0.336 | 0.005 | 0.352 | Farnesoid X receptor antagonist | 0.352 0.004 DBMET03442 | DBMET03442 | |
| 0.328 | 0.002 | 0.328 | 5-Alpha-reductase 1 inhibitor | 0.149 0.004 DBMET03442 | ||
| 0.328 | 0.002 | 0.328 | 5-Alpha-reductase 2 inhibitor | 0.199 0.003 DBMET03442 | ||
| 0.354 | 0.029 | 0.354 | Anticonvulsant | |||
| 0.324 | 0.001 | 0.324 | GABA uptake inhibitor | 0.142 0.002 DBMET03442 | ||
| 0.318 | 0.005 | 0.377 | Estrogen antagonist | 0.377 0.005 DBMET03442 | DBMET03442 | |
| 0.31 | 0.003 | 0.325 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.325 0.003 DBMET03442 | DBMET03442 | |
| 0.299 | 0.002 | 0.311 | Arachidonic acid antagonist | 0.311 0.001 DBMET03442 | DBMET03442 | |
| 0.273 | 0.005 | 0.273 | Estrogen agonist | 0.262 0.006 DBMET03442 | ||
| 0.27 | 0.003 | 0.27 | Glycine receptor agonist | 0.222 0.004 DBMET03442 | ||
| 0.326 | 0.06 | 0.326 | Aldehyde oxidase inhibitor | 0.257 0.08 DBMET03442 | ||
| 0.264 | 0.002 | 0.264 | Glycine receptor antagonist | 0.262 0.002 DBMET03442 | ||
| 0.259 | 0.003 | 0.259 | Glucocorticoid antagonist | 0.214 0.003 DBMET03442 | ||
| 0.325 | 0.07 | 0.325 | Immunomodulator | 0.272 0.099 DBMET03442 | ||
| 0.249 | 0.005 | 0.249 | Antineoplastic alkaloid | 0.246 0.005 DBMET03442 | ||
| 0.27 | 0.026 | 0.315 | Melanin inhibitor | 0.315 0.02 DBMET03442 | DBMET03442 | |
| 0.346 | 0.104 | 0.445 | Antibacterial | 0.445 0.059 DBMET03442 | DBMET03442 | |
| 0.314 | 0.075 | 0.362 | Immunostimulant | 0.362 0.061 DBMET03442 | DBMET03442 | |
| 0.236 | 0.002 | 0.316 | Progesterone agonist | 0.316 0.002 DBMET03442 | DBMET03442 | |
| 0.238 | 0.004 | 0.238 | Mineralocorticoid receptor antagonist | 0.127 0.005 DBMET03442 | ||
| 0.247 | 0.017 | 0.263 | DNA polymerase I inhibitor | 0.263 0.015 DBMET03442 | DBMET03442 | |
| 0.24 | 0.011 | 0.26 | Microtubule formation inhibitor | 0.26 0.006 DBMET03442 | DBMET03442 | |
| 0.234 | 0.007 | 0.234 | Estrogen receptor alpha antagonist | 0.178 0.009 DBMET03442 | ||
| 0.227 | 0.002 | 0.248 | Anabolic | 0.248 0.002 DBMET03442 | DBMET03442 | |
| 0.259 | 0.044 | 0.259 | RNA-directed DNA polymerase inhibitor | 0.246 0.052 DBMET03442 | ||
| 0.238 | 0.028 | 0.302 | Phospholipase C inhibitor | 0.302 0.018 DBMET03442 | DBMET03442 | |
| 0.197 | 0.005 | 0.197 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.125 0.008 DBMET03442 | ||
| 0.197 | 0.01 | 0.197 | Estrogen receptor beta antagonist | 0.16 0.014 DBMET03442 | ||
| 0.203 | 0.021 | 0.246 | Antineoplastic antibiotic | 0.246 0.015 DBMET03442 | DBMET03442 | |
| 0.247 | 0.071 | 0.282 | Angiogenesis stimulant | 0.282 0.056 DBMET03442 | DBMET03442 | |
| 0.186 | 0.011 | 0.186 | Prolactin inhibitor | 0.118 0.04 DBMET03442 | ||
| 0.2 | 0.028 | 0.274 | Neurotrophic factor | 0.274 0.009 DBMET03442 | DBMET03442 | |
| 0.25 | 0.081 | 0.25 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.145 DBMET03442 | ||
| 0.172 | 0.003 | 0.172 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.101 0.004 DBMET03442 | ||
| 0.249 | 0.084 | 0.29 | Antioxidant | 0.29 0.065 DBMET03442 | DBMET03442 | |
| 0.17 | 0.005 | 0.17 | Estrogen receptor alpha agonist | 0.148 0.005 DBMET03442 | ||
| 0.168 | 0.004 | 0.172 | Na+ K+ transporting ATPase inhibitor | 0.172 0.003 DBMET03442 | DBMET03442 | |
| 0.278 | 0.114 | 0.278 | Calcium channel activator | 0.245 0.153 DBMET03442 | ||
| 0.265 | 0.103 | 0.331 | Interleukin 2 agonist | 0.331 0.055 DBMET03442 | DBMET03442 | |
| 0.193 | 0.034 | 0.193 | Anesthetic local | 0.157 0.046 DBMET03442 | ||
| 0.157 | 0 | 0.157 | Transcortin receptor antagonist | 0.141 0 DBMET03442 | ||
| 0.196 | 0.043 | 0.222 | Protein kinase stimulant | 0.222 0.035 DBMET03442 | DBMET03442 | |
| 0.173 | 0.023 | 0.191 | Pregnane X receptor agonist | 0.191 0.013 DBMET03442 | DBMET03442 | |
| 0.165 | 0.017 | 0.165 | Acetylcholine nicotinic antagonist | 0.14 0.023 DBMET03442 | ||
| 0.147 | 0.004 | 0.147 | Estrone sulfatase inhibitor | 0.107 0.004 DBMET03442 | ||
| 0.151 | 0.007 | 0.16 | Bile acid receptor antagonist | 0.16 0.006 DBMET03442 | DBMET03442 | |
| 0.162 | 0.021 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.165 0.017 DBMET03442 | DBMET03442 | |
| 0.225 | 0.089 | 0.246 | DNA synthesis inhibitor | 0.246 0.069 DBMET03442 | DBMET03442 | |
| 0.137 | 0.002 | 0.17 | Lipocortins synthesis agonist | 0.17 0.001 DBMET03442 | DBMET03442 | |
| 0.168 | 0.038 | 0.183 | Alkylator | 0.183 0.032 DBMET03442 | DBMET03442 | |
| 0.141 | 0.014 | 0.141 | CDC25A inhibitor | 0.126 0.017 DBMET03442 | ||
| 0.177 | 0.052 | 0.177 | Lipid peroxidase inhibitor | 0.138 0.077 DBMET03442 | ||
| 0.133 | 0.008 | 0.133 | Estrogen receptor beta agonist | 0.121 0.009 DBMET03442 | ||
| 0.161 | 0.041 | 0.161 | Aldehyde dehydrogenase inhibitor | |||
| 0.14 | 0.027 | 0.14 | NMDA receptor antagonist | |||
| 0.147 | 0.034 | 0.157 | Mucolytic | 0.157 0.028 DBMET03442 | DBMET03442 | |
| 0.208 | 0.105 | 0.218 | Hypoglycemic | 0.218 0.097 DBMET03442 | DBMET03442 | |
| 0.1 | 0.004 | 0.1 | Pregnane X receptor antagonist | 0.09 0.004 DBMET03442 | ||
| 0.136 | 0.041 | 0.15 | Expectorant | 0.15 0.035 DBMET03442 | DBMET03442 | |
| 0.097 | 0.003 | 0.097 | Glucocorticoid agonist | 0.068 0.003 DBMET03442 | ||
| 0.169 | 0.075 | 0.18 | Antipruritic | 0.18 0.064 DBMET03442 | DBMET03442 | |
| 0.185 | 0.093 | 0.475 | Interleukin antagonist | 0.475 0.022 DBMET03442 | DBMET03442 | |
| 0.141 | 0.049 | 0.141 | Vanilloid 1 agonist | 0.117 0.095 DBMET03442 | ||
| 0.205 | 0.116 | 0.28 | Interleukin agonist | 0.28 0.059 DBMET03442 | DBMET03442 | |
| 0.091 | 0.002 | 0.091 | Corticosteroid-like | 0.06 0.003 DBMET03442 | ||
| 0.085 | 0.002 | 0.096 | Hedgehog signaling activator | 0.096 0.001 DBMET03442 | DBMET03442 | |
| 0.087 | 0.005 | 0.098 | Farnesoid X receptor agonist | 0.098 0.004 DBMET03442 | DBMET03442 | |
| 0.126 | 0.044 | 0.126 | AMP-activated protein kinase stimulant | 0.11 0.058 DBMET03442 | ||
| 0.121 | 0.046 | 0.121 | Acetylcholine release stimulant | |||
| 0.086 | 0.012 | 0.086 | Heme oxygenase stimulant | 0.077 0.018 DBMET03442 | ||
| 0.086 | 0.014 | 0.086 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 DBMET03442 | ||
| 0.082 | 0.011 | 0.082 | Potassium channel Kv1.3 blocker | 0.067 0.017 DBMET03442 | ||
| 0.143 | 0.075 | 0.177 | Adenylate cyclase stimulant | 0.177 0.028 DBMET03442 | DBMET03442 | |
| 0.103 | 0.036 | 0.11 | Transcription factor NF kappa B stimulant | 0.11 0.031 DBMET03442 | DBMET03442 | |
| 0.125 | 0.059 | 0.145 | Monophenol monooxygenase inhibitor | 0.145 0.049 DBMET03442 | DBMET03442 | |
| 0.081 | 0.021 | 0.081 | NMDA 2B receptor antagonist | 0.074 0.023 DBMET03442 | ||
| 0.06 | 0.011 | 0.06 | Parathyroid hormone antagonist | 0.056 0.014 DBMET03442 | ||
| 0.199 | 0.15 | 0.225 | Gastrin inhibitor | 0.225 0.112 DBMET03442 | DBMET03442 | |
| 0.116 | 0.068 | 0.116 | Proteasome inhibitor | |||
| 0.045 | 0.003 | 0.063 | Vitamin D receptor agonist | 0.063 0.002 DBMET03442 | DBMET03442 | |
| 0.042 | 0.002 | 0.042 | Progesterone receptor A antagonist | 0.014 0.004 DBMET03442 | ||
| 0.044 | 0.005 | 0.059 | Vitamin D receptor antagonist | 0.059 0.004 DBMET03442 | DBMET03442 | |
| 0.179 | 0.14 | 0.233 | Cardiotonic | 0.233 0.094 DBMET03442 | DBMET03442 | |
| 0.07 | 0.036 | 0.07 | NMDA receptor agonist | |||
| 0.055 | 0.023 | 0.055 | Cholesterol esterase inhibitor | 0.054 0.024 DBMET03442 | ||
| 0.054 | 0.023 | 0.058 | Microtubule stabilization | 0.058 0.017 DBMET03442 | DBMET03442 | |
| 0.084 | 0.055 | 0.084 | Inducible nitric-oxide synthase inhibitor | |||
| 0.051 | 0.023 | 0.051 | Opioid kappa receptor agonist | 0.045 0.028 DBMET03442 | ||
| 0.028 | 0.002 | 0.028 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.019 0.003 DBMET03442 | ||
| 0.105 | 0.08 | 0.105 | Adenylate cyclase inhibitor | 0.094 0.089 DBMET03442 | ||
| 0.081 | 0.056 | 0.081 | Opioid kappa receptor antagonist | |||
| 0.198 | 0.173 | 0.295 | Caspase 3 stimulant | 0.295 0.081 DBMET03442 | DBMET03442 | |
| 0.109 | 0.084 | 0.109 | Cholinergic antagonist | |||
| 0.141 | 0.117 | 0.254 | Platelet adhesion inhibitor | 0.254 0.048 DBMET03442 | DBMET03442 | |
| 0.106 | 0.085 | 0.106 | Acetylcholine antagonist | |||
| 0.081 | 0.063 | 0.081 | Estrogen-related receptor beta agonist | |||
| 0.122 | 0.104 | 0.122 | CC chemokine 6 receptor antagonist | |||
| 0.087 | 0.072 | 0.087 | ABCA1 expression enhancer | |||
| 0.035 | 0.022 | 0.041 | Tubulin agonist | 0.041 0.014 DBMET03442 | DBMET03442 | |
| 0.021 | 0.011 | 0.021 | Progesterone receptor B antagonist | 0.018 0.017 DBMET03442 | ||
| 0.05 | 0.04 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.078 0.02 DBMET03442 | DBMET03442 | |
| 0.071 | 0.064 | 0.071 | Keratolytic | 0.071 0.062 DBMET03442 | ||
| 0.033 | 0.026 | 0.04 | HMG CoA reductase inhibitor | 0.04 0.015 DBMET03442 | DBMET03442 | |
| 0.077 | 0.071 | 0.077 | Ornithine decarboxylase inhibitor | |||
| 0.092 | 0.087 | 0.092 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.017 | 0.013 | 0.021 | Telomerase stimulant | 0.021 0.006 DBMET03442 | DBMET03442 | |
| 0.016 | 0.013 | 0.023 | Ileal bile acid transport inhibitor | 0.023 0.007 DBMET03442 | DBMET03442 | |
| 0.036 | 0.034 | 0.036 | Vanilloid 3 antagonist | |||
| 0.015 | 0.013 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 DBMET03442 | ||
| 0.033 | 0.033 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.029 DBMET03442 | DBMET03442 | |
| 0.093 | 0.115 | 0.108 | Bone formation stimulant | 0.108 0.097 DBMET03442 | DBMET03442 | |
| 0.047 | 0.069 | 0.068 | Acetyl-CoA transferase 2 inhibitor | 0.068 0.019 DBMET03442 | DBMET03442 | |
| 0.073 | 0.102 | 0.084 | T cell inhibitor | 0.084 0.051 DBMET03442 | DBMET03442 | |
| 0.146 | 0.204 | 0.194 | Peptidyltransferase inhibitor | 0.194 0.108 DBMET03442 | DBMET03442 | |
| 0.166 | 0.225 | 0.258 | Antithrombotic | 0.258 0.12 DBMET03442 | DBMET03442 | |
| 0.125 | 0.195 | 0.465 | Tumour necrosis factor alpha release inhibitor | 0.465 0.018 DBMET03442 | DBMET03442 | |
| 0.142 | 0.226 | 0.176 | Transcription factor STAT3 inhibitor | 0.176 0.171 DBMET03442 | DBMET03442 | |
| 0.062 | 0.187 | 0.104 | Toll-Like receptor 4 antagonist | 0.104 0.064 DBMET03442 | DBMET03442 | |
| 0.101 | 0.239 | 0.144 | ATPase inhibitor | 0.144 0.112 DBMET03442 | DBMET03442 | |
| 0.004 | 0.15 | 0.022 | Prostacyclin agonist | 0.022 0.008 DBMET03442 | DBMET03442 | |
| 0.008 | 0.168 | 0.042 | Prostaglandin D2 agonist | 0.042 0.011 DBMET03442 | DBMET03442 | |
| 0.028 | 0.503 | 0.154 | Platelet antagonist | 0.154 0.14 DBMET03442 | DBMET03442 | |
| 0.013 | 0.495 | 0.071 | Prostaglandin F2 alpha antagonist | 0.071 0.032 DBMET03442 | DBMET03442 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |